{"id":"colchicine-only","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Diarrhea"},{"rate":"5-15","effect":"Nausea"},{"rate":"5-15","effect":"Abdominal pain"},{"rate":"1-5","effect":"Myopathy"},{"rate":"1-5","effect":"Peripheral neuropathy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Colchicine binds to β-tubulin and prevents microtubule assembly, which disrupts cell division and inflammatory cell movement. This leads to reduced recruitment of neutrophils and other immune cells to sites of inflammation, and decreases the production of inflammatory mediators like IL-1β and TNF-α. The drug has been used for decades in gout and is now being investigated for cardiovascular and other inflammatory indications.","oneSentence":"Colchicine inhibits microtubule polymerization by binding to tubulin, thereby suppressing inflammatory cell migration and activation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:06:36.097Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute gout flare prophylaxis and treatment"},{"name":"Familial Mediterranean fever"},{"name":"Cardiovascular disease (post-myocardial infarction, atherosclerosis) — Phase 3 investigation"}]},"trialDetails":[{"nctId":"NCT07362966","phase":"PHASE4","title":"Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-02-24","conditions":"Colchicine, Coronary Atherosclerosis Management, Clonal Hematopoiesis of Indeterminate Potential","enrollment":120},{"nctId":"NCT07349875","phase":"PHASE4","title":"Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-01","conditions":"Coronary Artery Disease (CAD)","enrollment":3826},{"nctId":"NCT06802926","phase":"PHASE4","title":"Pilot Trial of Colchicine for Graft Failure in CABG","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-12-29","conditions":"CABG, Graft Failure, Colchicine","enrollment":100},{"nctId":"NCT06765356","phase":"PHASE4","title":"Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias","status":"RECRUITING","sponsor":"Vivek Reddy","startDate":"2025-04-15","conditions":"Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Long-standing Persistent Atrial Fibrillation","enrollment":275},{"nctId":"NCT04875702","phase":"PHASE4","title":"Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-02-22","conditions":"Gout","enrollment":650},{"nctId":"NCT06847204","phase":"PHASE1, PHASE2","title":"EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL","status":"COMPLETED","sponsor":"Zaeema Kanwal","startDate":"2025-02-24","conditions":"COVID - 19","enrollment":66},{"nctId":"NCT07129538","phase":"NA","title":"Outcomes of Inspiratory Muscle Training in FMF Adolescents","status":"RECRUITING","sponsor":"Cairo University","startDate":"2025-05-10","conditions":"Familial Mediterranean Fever","enrollment":40},{"nctId":"NCT06936709","phase":"PHASE4","title":"Perioperative Colchicine for TKA","status":"NOT_YET_RECRUITING","sponsor":"Geisinger Clinic","startDate":"2025-12-01","conditions":"Osteoarthritis of Knee, Recovery Following Primary Total Knee Arthroplasty, Perioperative Pain Control","enrollment":75},{"nctId":"NCT07074990","phase":"NA","title":"Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-11-01","conditions":"Sepsis at Intensive Care Unit","enrollment":46},{"nctId":"NCT04870424","phase":"PHASE3","title":"Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2021-09-21","conditions":"Transcatheter Aortic Valve Replacement, Atrial Fibrillation New Onset, Pacemaker","enrollment":120},{"nctId":"NCT06666335","phase":"PHASE4","title":"A Study to Evaluate Efficacy and Safety of Anakinra in Chinese Patients With Colchicine-resistent FMF","status":"NOT_YET_RECRUITING","sponsor":"Swedish Orphan Biovitrum","startDate":"2025-09-01","conditions":"Familial Mediterranean Fever (FMF )","enrollment":3},{"nctId":"NCT05472337","phase":"PHASE2","title":"Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome","status":"RECRUITING","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2022-08-01","conditions":"Acute Coronary Syndrome","enrollment":50},{"nctId":"NCT06763055","phase":"PHASE3","title":"The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL","status":"RECRUITING","sponsor":"The George Institute","startDate":"2025-02-27","conditions":"Intracerebral Hemorrhage, Spontaneous Intracerebral Hemorrhage, Supratentorial Intracerebral Haemorrhage","enrollment":2000},{"nctId":"NCT02898610","phase":"PHASE3","title":"Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke","status":"COMPLETED","sponsor":"University College Dublin","startDate":"2016-12-12","conditions":"Ischemic Attack, Transient, Stroke","enrollment":3154},{"nctId":"NCT06813079","phase":"PHASE2","title":"Using Tumor Models to Determine Treatments","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-02-17","conditions":"Pancreatic Ductal Carcinoma, Advanced Cancer, Epithelial Tumor","enrollment":25},{"nctId":"NCT03913442","phase":"PHASE4","title":"Colchicine for the Treatment of Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2019-05-15","conditions":"Osteoarthritis, Osteo Arthritis Knee","enrollment":120},{"nctId":"NCT05936281","phase":"PHASE2","title":"A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-07-20","conditions":"Gout, Gout Initiating Urate-loweringUrate-lowering Therapy","enrollment":165},{"nctId":"NCT06158698","phase":"PHASE3","title":"CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine","status":"RECRUITING","sponsor":"Niguarda Hospital","startDate":"2023-11-14","conditions":"Cardiomyopathies, Myocarditis, Inflammatory Cardiomyopathy","enrollment":80},{"nctId":"NCT06352632","phase":"PHASE3","title":"ACT-GLOBAL Adaptive Platform Trial for Stroke","status":"RECRUITING","sponsor":"The George Institute","startDate":"2024-09-26","conditions":"Stroke","enrollment":20000},{"nctId":"NCT05936268","phase":"PHASE2","title":"Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-07-21","conditions":"Acute Gout, Gout Flare","enrollment":106},{"nctId":"NCT05418686","phase":"NA","title":"Study of Colchicine Resistance in Familial Mediterranean Fever","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-12-09","conditions":"Mediterranean Fever, Colchicine Resistance","enrollment":30},{"nctId":"NCT04324463","phase":"PHASE3","title":"Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2020-04-21","conditions":"Coronavirus, Severe Acute Respiratory Syndrome","enrollment":6667},{"nctId":"NCT04381936","phase":"PHASE3","title":"Randomised Evaluation of COVID-19 Therapy","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2020-03-19","conditions":"Severe Acute Respiratory Syndrome","enrollment":70000},{"nctId":"NCT06062277","phase":"PHASE2","title":"COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)","status":"UNKNOWN","sponsor":"University College Dublin","startDate":"2023-10","conditions":"Ischemic Stroke, Atherosclerosis","enrollment":91},{"nctId":"NCT06054100","phase":"PHASE3","title":"The Effect of Colchicine on Inflammation in ACS Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-02-01","conditions":"Acute Coronary Syndrome, STEMI","enrollment":88},{"nctId":"NCT04818489","phase":"PHASE4","title":"Colchicine and Post-COVID-19 Pulmonary Fibrosis","status":"UNKNOWN","sponsor":"ClinAmygate","startDate":"2021-03-25","conditions":"Covid19, Pulmonary Fibrosis Interstitial","enrollment":260},{"nctId":"NCT04756128","phase":"PHASE2","title":"Impact of Colchicine and Low-dose Naltrexone on COVID-19","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2021-01-25","conditions":"Covid19","enrollment":142},{"nctId":"NCT05930002","phase":"NA","title":"Role of Ivermectin and Colchicine in Treatment of COVID-19: Randomized Controlled Clinical Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-07-21","conditions":"COVID-19","enrollment":120},{"nctId":"NCT05805930","phase":"PHASE3","title":"Therapeutic Approach in Colchicine-resistant Recurrent pEricarditis in Children","status":"NOT_YET_RECRUITING","sponsor":"Istituto Giannina Gaslini","startDate":"2023-06-01","conditions":"Pericarditis","enrollment":48},{"nctId":"NCT05802992","phase":"PHASE3","title":"The Efficacy and Safety of Colchicine Combined With Conventional Therapy in Multiple Myeloma Patients","status":"UNKNOWN","sponsor":"Affiliated Hospital of Nantong University","startDate":"2022-03-30","conditions":"Multiple Myeloma","enrollment":30},{"nctId":"NCT04492358","phase":"PHASE2, PHASE3","title":"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center","status":"TERMINATED","sponsor":"Maria Joyera Rodríguez","startDate":"2020-10-22","conditions":"Covid19","enrollment":54},{"nctId":"NCT04949516","phase":"PHASE4","title":"Mono Antiplatelet and Colchicine Therapy","status":"COMPLETED","sponsor":"Wonkwang University Hospital","startDate":"2021-06-15","conditions":"Acute Coronary Syndrome, Drug-Eluting Stents","enrollment":200},{"nctId":"NCT05648734","phase":"","title":"Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2022-03-10","conditions":"Post-COVID-19 Syndrome, Lung Fibrosis","enrollment":200},{"nctId":"NCT04375202","phase":"PHASE2","title":"Colchicine in COVID-19: a Pilot Study","status":"TERMINATED","sponsor":"University Of Perugia","startDate":"2020-04-18","conditions":"COVID-19","enrollment":227},{"nctId":"NCT04355143","phase":"PHASE2","title":"Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19)","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2020-05-01","conditions":"COVID-19","enrollment":93},{"nctId":"NCT04762771","phase":"PHASE1, PHASE2","title":"Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)","status":"TERMINATED","sponsor":"Baptist Health South Florida","startDate":"2020-12-23","conditions":"Covid19","enrollment":2},{"nctId":"NCT05324423","phase":"PHASE1","title":"To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout","status":"UNKNOWN","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2021-10-18","conditions":"Gout","enrollment":20},{"nctId":"NCT04355585","phase":"PHASE1","title":"Revisiting the Mechanism of the Anti-inflammatory Effect of Colchicine","status":"UNKNOWN","sponsor":"Brigham and Women's Hospital","startDate":"2020-05-06","conditions":"Colchicine Mechanism of Action","enrollment":18},{"nctId":"NCT05151614","phase":"PHASE1","title":"Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection","status":"COMPLETED","sponsor":"University of Baghdad","startDate":"2021-04-01","conditions":"COVID-19 Pandemic","enrollment":160},{"nctId":"NCT03226899","phase":"PHASE4","title":"A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment","status":"TERMINATED","sponsor":"Ironwood Pharmaceuticals, Inc.","startDate":"2017-07-19","conditions":"Gout, Chronic Kidney Disease (CKD)","enrollment":242},{"nctId":"NCT05038449","phase":"NA","title":"Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19","status":"UNKNOWN","sponsor":"Shanghai Public Health Clinical Center","startDate":"2021-09-06","conditions":"Covid19, Colchicine","enrollment":60},{"nctId":"NCT04997551","phase":"PHASE3","title":"Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19","status":"UNKNOWN","sponsor":"Biogipuzkoa Health Research Institute","startDate":"2020-09-08","conditions":"COVID-19 Infection","enrollment":752},{"nctId":"NCT04867226","phase":"PHASE2","title":"Effectiveness of Colchicine Among Patients With COVID-19 Infection","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2021-05-08","conditions":"Coronavirus Infection","enrollment":100},{"nctId":"NCT04328480","phase":"PHASE3","title":"The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.","status":"COMPLETED","sponsor":"Estudios Clínicos Latino América","startDate":"2020-04-17","conditions":"COVID-19","enrollment":1279},{"nctId":"NCT04527562","phase":"NA","title":"Colchicine in Moderate Symptomatic COVID-19 Patients","status":"COMPLETED","sponsor":"Dhaka Medical College","startDate":"2020-07-14","conditions":"Covid19","enrollment":299},{"nctId":"NCT04377321","phase":"","title":"Colchicine Has Anti-diabetic Effect","status":"COMPLETED","sponsor":"Ministry of Health and Population, Egypt","startDate":"2019-10-10","conditions":"Treatment Adherence","enrollment":150},{"nctId":"NCT02153983","phase":"PHASE1, PHASE2","title":"Effects of Colchicine in Non-Diabetic Adults With Metabolic Syndrome","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2014-05-31","conditions":"Obesity, Metabolic Disease","enrollment":77},{"nctId":"NCT03131583","phase":"PHASE1","title":"The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2017-02-17","conditions":"Gout","enrollment":15},{"nctId":"NCT01994226","phase":"PHASE4","title":"Colchicine Or Naproxen Treatment for ACute gouT","status":"COMPLETED","sponsor":"Keele University","startDate":"2014-01","conditions":"Gout","enrollment":399},{"nctId":"NCT02995512","phase":"PHASE4","title":"Mechanistic Effects of Colchicine in Patients With Myocardial Infarction","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2017-05-01","conditions":"Myocardial Infarction","enrollment":""},{"nctId":"NCT02582190","phase":"PHASE3","title":"COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF","status":"WITHDRAWN","sponsor":"Elpen Pharmaceutical Co. Inc.","startDate":"2017-12-02","conditions":"Atrial Fibrillation","enrollment":""},{"nctId":"NCT01148797","phase":"PHASE2","title":"Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-12","conditions":"Colchicine Resistant/Intolerant Familial Mediterranean Fever","enrollment":15},{"nctId":"NCT01399008","phase":"PHASE2","title":"Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2011-06","conditions":"Gout","enrollment":100},{"nctId":"NCT02175589","phase":"PHASE2","title":"Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation","status":"UNKNOWN","sponsor":"Rambam Health Care Campus","startDate":"2014-06","conditions":"Familial Mediterranean Fever","enrollment":80},{"nctId":"NCT01029652","phase":"PHASE3","title":"Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-12","conditions":"Acute Gout","enrollment":230},{"nctId":"NCT01481233","phase":"PHASE2","title":"Oral Colchicine in Men With Castrate Resistant Prostate Cancer","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2013-05","conditions":"Prostate Cancer","enrollment":""},{"nctId":"NCT01932268","phase":"PHASE2","title":"A Pilot Study for Pharmacokinetic Parameter of Colchicine in Patient Taking Rifampin","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2011-01","conditions":"Chronic Kidney Disease, Tuberculosis","enrollment":2},{"nctId":"NCT00506883","phase":"PHASE3","title":"MPC-004 for the Treatment of an Acute Gout Flare","status":"COMPLETED","sponsor":"Takeda","startDate":"2007-04","conditions":"Gout","enrollment":185},{"nctId":"NCT01084278","phase":"PHASE4","title":"Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)","status":"COMPLETED","sponsor":"Takeda","startDate":"2010-05","conditions":"Pharmacokinetics","enrollment":40},{"nctId":"NCT00798369","phase":"PHASE2","title":"Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients","status":"COMPLETED","sponsor":"Novartis","startDate":"2008-11","conditions":"Acute Gout","enrollment":200},{"nctId":"NCT00984009","phase":"PHASE1","title":"A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-09","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT00960193","phase":"PHASE1","title":"Drug-Food Interaction Study of Seville Orange Juice and Colchicine","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2009-02","conditions":"Healthy","enrollment":24},{"nctId":"NCT01001052","phase":"PHASE1","title":"Relative Bioavailability of Colcrys™ 0.6 mg Tablets in Healthy Young and Elderly Volunteers Under Fasted Conditions","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2009-10","conditions":"Healthy","enrollment":38},{"nctId":"NCT00960323","phase":"PHASE1","title":"Drug-Drug Interaction Study Between Colchicine and Atorvastatin","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2009-02","conditions":"Healthy","enrollment":24},{"nctId":"NCT00983905","phase":"PHASE1","title":"Drug-Drug Interaction Study of Colchicine and Theophylline","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-08","conditions":"Pharmacokinetics","enrollment":30},{"nctId":"NCT01021020","phase":"PHASE1","title":"Bioequivalence Study of Colchicine Tablets","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2007-09","conditions":"Healthy","enrollment":28},{"nctId":"NCT01017003","phase":"PHASE1","title":"Pharmacokinetic Study With Colchicine in Healthy Volunteers","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2007-09","conditions":"Pharmacokinetics","enrollment":14},{"nctId":"NCT00983294","phase":"PHASE1","title":"Drug-Drug Interaction Study of Colchicine and Azithromycin","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-07","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT00983931","phase":"PHASE1","title":"Drug-Drug Interaction Study Between Colchicine and Cyclosporine","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-08","conditions":"Pharmacokinetics, Healthy","enrollment":24},{"nctId":"NCT00983216","phase":"PHASE1","title":"Drug-Drug Interaction Study Between Colchicine and Ketoconazole","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-07","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT00983372","phase":"PHASE1","title":"Drug-Drug Interaction Study Between Colchicine and Diltiazem ER","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-08","conditions":"Healthy; Adult; Volunteer; Colchicine; Pharmacokinetics; Diltiazem; Cytochrome p450 3A4; P-glycoprotein","enrollment":24},{"nctId":"NCT00983515","phase":"PHASE1","title":"Drug-Drug Interaction Between Colchicine and Ritonavir","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-07","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT00983242","phase":"PHASE1","title":"Drug-Drug Interaction Between Colchicine and Verapamil ER","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2008-09","conditions":"Pharmacokinetics","enrollment":24},{"nctId":"NCT00984061","phase":"PHASE1","title":"Drug-Drug Interaction Study of Colchicine and Clarithromycin","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2007-11","conditions":"Pharmacokinetics","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3056,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Colchicine only","genericName":"Colchicine only","companyName":"The George Institute","companyId":"the-george-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Colchicine inhibits microtubule polymerization by binding to tubulin, thereby suppressing inflammatory cell migration and activation. Used for Acute gout flare prophylaxis and treatment, Familial Mediterranean fever, Cardiovascular disease (post-myocardial infarction, atherosclerosis) — Phase 3 investigation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}